ATE99281T1 - Verfahren zur herstellung von 7-substituierten hept-6-en- und heptansaeuren und derivaten davon. - Google Patents
Verfahren zur herstellung von 7-substituierten hept-6-en- und heptansaeuren und derivaten davon.Info
- Publication number
- ATE99281T1 ATE99281T1 AT89118906T AT89118906T ATE99281T1 AT E99281 T1 ATE99281 T1 AT E99281T1 AT 89118906 T AT89118906 T AT 89118906T AT 89118906 T AT89118906 T AT 89118906T AT E99281 T1 ATE99281 T1 AT E99281T1
- Authority
- AT
- Austria
- Prior art keywords
- derivatives
- preparation
- heptanoic acids
- hept
- substituted
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 2
- -1 7-SUBSTITUTED HEPT-6-EN Chemical class 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- 125000004185 ester group Chemical group 0.000 abstract 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 abstract 1
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 abstract 1
- 241000845077 Iare Species 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000422 delta-lactone group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical group 0.000 abstract 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C223/00—Compounds containing amino and —CHO groups bound to the same carbon skeleton
- C07C223/02—Compounds containing amino and —CHO groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/367—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of functional groups containing oxygen only in singly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
- C07C59/48—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Obesity (AREA)
- Veterinary Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25747588A | 1988-10-13 | 1988-10-13 | |
| US35553189A | 1989-05-22 | 1989-05-22 | |
| EP89118906A EP0363934B1 (de) | 1988-10-13 | 1989-10-11 | Verfahren zur Herstellung von 7-substituierten Hept-6-en- und Heptansäuren und Derivaten davon |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE99281T1 true ATE99281T1 (de) | 1994-01-15 |
Family
ID=26945992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT89118906T ATE99281T1 (de) | 1988-10-13 | 1989-10-11 | Verfahren zur herstellung von 7-substituierten hept-6-en- und heptansaeuren und derivaten davon. |
Country Status (24)
| Country | Link |
|---|---|
| EP (2) | EP0363934B1 (de) |
| JP (1) | JP2853227B2 (de) |
| KR (1) | KR0162656B1 (de) |
| AT (1) | ATE99281T1 (de) |
| AU (1) | AU636122B2 (de) |
| BG (1) | BG60555B1 (de) |
| CA (1) | CA2000553C (de) |
| CZ (1) | CZ283316B6 (de) |
| DE (1) | DE68911834T2 (de) |
| DK (1) | DK175073B1 (de) |
| ES (1) | ES2060712T3 (de) |
| FI (1) | FI98063C (de) |
| HK (1) | HK49496A (de) |
| HU (1) | HU207993B (de) |
| IE (2) | IE940109L (de) |
| IL (1) | IL91941A (de) |
| MY (1) | MY105067A (de) |
| NO (1) | NO174623C (de) |
| NZ (1) | NZ230973A (de) |
| RO (1) | RO109732B1 (de) |
| SG (1) | SG139553A1 (de) |
| SK (1) | SK579789A3 (de) |
| WO (1) | WO1990003962A1 (de) |
| YU (1) | YU48466B (de) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5118853A (en) * | 1988-10-13 | 1992-06-02 | Sandoz Ltd. | Processes for the synthesis of 3-disubstituted aminoacroleins |
| US5290946A (en) * | 1988-10-13 | 1994-03-01 | Sandoz Ltd. | Processes for the synthesis of 3-(substituted indolyl-2-yl)propenaldehydes |
| CA2027179A1 (en) * | 1989-10-10 | 1991-04-11 | Barry C. Ross | Chemical compounds |
| DE4424525A1 (de) * | 1994-07-12 | 1995-01-26 | Elmar Meyer | Dauermagnet-Kolbenmotor |
| GT199800127A (es) | 1997-08-29 | 2000-02-01 | Combinaciones terapeuticas. | |
| NZ517468A (en) | 1999-08-30 | 2004-02-27 | Aventis Pharma Gmbh | Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
| IL152580A0 (en) | 2000-05-26 | 2003-05-29 | Ciba Sc Holding Ag | Process for the preparation of indole derivatives and intermediates of the process |
| US7777006B2 (en) | 2002-12-31 | 2010-08-17 | Csl Behring L.L.C. | Method for purification of alpha-1-antitrypsin |
| KR20050114282A (ko) * | 2003-04-24 | 2005-12-05 | 다이셀 가가꾸 고교 가부시끼가이샤 | 광학 활성의 디히드록시헵텐산 에스테르의 분리 방법 |
| US7368581B2 (en) | 2003-06-18 | 2008-05-06 | Teva Pharmaceutical Industries Ltd. | Process for the preparation of fluvastatin sodium crystal from XIV |
| US7368468B2 (en) | 2003-06-18 | 2008-05-06 | Teva Pharmaceutical Industries Ltd. | Fluvastatin sodium crystal forms XIV, LXXIII, LXXIX, LXXX and LXXXVII, processes for preparing them, compositions containing them and methods of using them |
| EP1719759A3 (de) | 2003-06-18 | 2007-03-21 | Teva Pharmaceutical Industries, Inc. | Fluvastatin-Natrium-Kristallmodifikation LXXIII, Verfahren zu deren Herstellung, Zusammensetzungen, die diese enthalten und Verfahren zu deren Anwendung |
| WO2005053683A1 (en) | 2003-11-26 | 2005-06-16 | Duke University | A method of preventing or treating glaucoma |
| US7851624B2 (en) | 2003-12-24 | 2010-12-14 | Teva Pharamaceutical Industries Ltd. | Triol form of rosuvastatin and synthesis of rosuvastatin |
| US20060211752A1 (en) | 2004-03-16 | 2006-09-21 | Kohn Leonard D | Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression |
| US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
| US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| ES2327668T3 (es) | 2006-04-20 | 2009-11-02 | F.I.S. Fabbrica Italiana Sintetici S.P.A. | Procedimiento para la preparacion de sal sodica de fluvastatina. |
| EP2373609B1 (de) | 2008-12-19 | 2013-10-16 | KRKA, D.D., Novo Mesto | Verwendung amphiphiler verbindungen zur kontrollierten kristallisation von statinen und statinzwischenprodukten |
| EP2327682A1 (de) | 2009-10-29 | 2011-06-01 | KRKA, D.D., Novo Mesto | Verwendung von amphiphilen Verbindungen zur gesteuerten Kristallisation von Statinen und Statin Zwischenprodukte. |
| AU2013214693B2 (en) | 2012-02-02 | 2017-02-23 | Kenneth Gek-Jin OOI | Improvements in tear film stability |
| JP2016516804A (ja) | 2013-04-17 | 2016-06-09 | ファイザー・インク | 心血管疾患を治療するためのｎ−ピペリジン−３−イルベンズアミド誘導体 |
| WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
| AU2020209215B2 (en) | 2019-01-18 | 2023-02-02 | Astrazeneca Ab | PCSK9 inhibitors and methods of use thereof |
| WO2025168652A1 (en) | 2024-02-05 | 2025-08-14 | Astrazeneca Ab | Azd-0780 in combination with a statin for use in lowering ldl-c levels and treating cardiovacular diseases |
| WO2025196153A1 (en) | 2024-03-20 | 2025-09-25 | Astrazeneca Ab | Pcsk9 inhibitors and methods of use thereof |
| WO2025196155A1 (en) | 2024-03-20 | 2025-09-25 | Astrazeneca Ab | Pcsk9 inhibitors and methods of use thereof |
| TW202539678A (zh) | 2024-03-20 | 2025-10-16 | 瑞典商阿斯特捷利康公司 | Ｐｃｓｋ９抑制劑及其使用方法 |
| WO2025238159A1 (en) | 2024-05-16 | 2025-11-20 | Astrazeneca Ab | Combination therapy comprising azd0780 and ezetimibe |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB945536A (en) * | 1961-09-08 | 1964-01-02 | Istituto Chemioterapico | Method of preparing ª -amino-acroleins |
| US4739073A (en) * | 1983-11-04 | 1988-04-19 | Sandoz Pharmaceuticals Corp. | Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof |
| WO1984002131A1 (fr) * | 1982-11-22 | 1984-06-07 | Sandoz Ag | Produits analogues de mevalolactone et leurs derives, leurs procedes de production, compositions pharmaceutiques les contenant ainsi que leur utilisation en tant que produits pharmaceutiques |
| US4571428A (en) * | 1983-07-08 | 1986-02-18 | Sandoz, Inc. | 6-Substituted-4-hydroxy-tetrahydropyran-2-ones |
| US4650890A (en) * | 1984-04-03 | 1987-03-17 | Sandoz Corp. | Preparation of olefinic compounds and intermediates thereof |
| ATE62906T1 (de) * | 1984-06-22 | 1991-05-15 | Sandoz Ag | Pyrazolanaloge von mevalonolakton und abkoemmlinge davon, verfahren zu deren herstellung und deren verwendung. |
| JPS62501009A (ja) * | 1984-12-04 | 1987-04-23 | サンド・アクチエンゲゼルシヤフト | メバロノラクトンのインデン同族体及びその誘導体 |
| US4668794A (en) * | 1985-05-22 | 1987-05-26 | Sandoz Pharm. Corp. | Intermediate imidazole acrolein analogs |
| EP0244364A3 (de) * | 1986-04-30 | 1992-04-01 | Sandoz Ag | Herstellung von olefinischen Verbindungen |
| PT85662B (pt) * | 1986-09-10 | 1990-06-29 | Sandoz Sa | Processo para a preparacao de derivados de aza-indol e de indolizina e de composicoes farmaceuticas que os contem |
-
1989
- 1989-10-11 AT AT89118906T patent/ATE99281T1/de not_active IP Right Cessation
- 1989-10-11 RO RO145326A patent/RO109732B1/ro unknown
- 1989-10-11 IE IE940109A patent/IE940109L/xx unknown
- 1989-10-11 DE DE68911834T patent/DE68911834T2/de not_active Expired - Lifetime
- 1989-10-11 NZ NZ230973A patent/NZ230973A/xx unknown
- 1989-10-11 EP EP89118906A patent/EP0363934B1/de not_active Expired - Lifetime
- 1989-10-11 AU AU43448/89A patent/AU636122B2/en not_active Expired
- 1989-10-11 WO PCT/EP1989/001201 patent/WO1990003962A1/en not_active Ceased
- 1989-10-11 ES ES89118906T patent/ES2060712T3/es not_active Expired - Lifetime
- 1989-10-11 MY MYPI89001403A patent/MY105067A/en unknown
- 1989-10-11 IL IL9194189A patent/IL91941A/en not_active IP Right Cessation
- 1989-10-11 SG SG200602066-3A patent/SG139553A1/en unknown
- 1989-10-11 EP EP19930106005 patent/EP0562643A3/en not_active Ceased
- 1989-10-11 KR KR1019900701243A patent/KR0162656B1/ko not_active Expired - Lifetime
- 1989-10-11 HU HU896048A patent/HU207993B/hu unknown
- 1989-10-11 IE IE327789A patent/IE63477B1/en not_active IP Right Cessation
- 1989-10-11 YU YU197389A patent/YU48466B/sh unknown
- 1989-10-11 JP JP1510605A patent/JP2853227B2/ja not_active Expired - Lifetime
- 1989-10-12 CZ CS895797A patent/CZ283316B6/cs not_active IP Right Cessation
- 1989-10-12 SK SK5797-89A patent/SK579789A3/sk unknown
- 1989-10-12 CA CA002000553A patent/CA2000553C/en not_active Expired - Lifetime
-
1990
- 1990-06-07 BG BG92179A patent/BG60555B1/bg unknown
- 1990-06-12 NO NO902598A patent/NO174623C/no unknown
- 1990-06-12 FI FI902935A patent/FI98063C/fi active IP Right Grant
- 1990-06-13 DK DK199001446A patent/DK175073B1/da not_active IP Right Cessation
-
1996
- 1996-03-21 HK HK49496A patent/HK49496A/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE68911834D1 (de) | Verfahren zur Herstellung von 7-substituierten Hept-6-en- und Heptansäuren und Derivaten davon. | |
| ES8103048A1 (es) | Un procedimiento para preparar derivados del acido 4-amino-3-quimoleincarboxilico. | |
| RU92016313A (ru) | Новые аналоги витамина d, способ их получения, промежуточное соединение, формкомпозиция и способ лечения | |
| DE69738154D1 (de) | Optische auflösung von methylphenidat mittels 0,0'-bisaroyl-weinsäuren | |
| ES8706622A1 (es) | Procedimiento para preparar alfa-aminoacidos sustituidos | |
| ATE117989T1 (de) | Prostaglandinanaloge enthaltende lipidemulsion. | |
| DK691288D0 (da) | Cyclopropanderivater | |
| ATE114637T1 (de) | Verfahren zur herstellung von antikonvulsanten cyclischen aminosäureverbindungen. | |
| EP0366041A3 (de) | Imido-percarbonsäuren | |
| ATE202071T1 (de) | Verfahren zur herstellung von alph-beta- ungesättigten trifluormethylcarboxylverbindungen | |
| ATE46322T1 (de) | Verfahren zur herstellung von bestatin-derivaten und deren zwischenprodukte. | |
| GB1514389A (en) | Glycerides with antibacterial properties | |
| MY101645A (en) | Phosphoric esters and process for preparing the same. | |
| KR900009533A (ko) | 아릴아세트산 모노 에스테르 및 그의 제조방법 | |
| ATE25680T1 (de) | Verfahren zur herstellung von 4-amino-5-dialkoxy- methylpyrimidinderivaten. | |
| GR1000469B (el) | Mεθοδος παρασκευης κινολινοκαρβοξυλικων οξεων. | |
| DE69619402D1 (de) | Verfahren zur herstellung von methoximinophenylglyoxylsäure-derivaten | |
| BG49274A3 (bg) | Метод за получаване на естери на l-аминодикарбонова киселина | |
| ATE123028T1 (de) | Phospholipase-a2-inhibitor, verfahren zu seiner herstellung und diesen enthaltende pharmazeutische oder veterinäre zusammensetzungen. | |
| ATE16696T1 (de) | Verfahren zur herstellung von 3-alkyl-6-methylbeta-resorcylsaeureestern. | |
| ATE103598T1 (de) | Verfahren zur herstellung von zwischenprodukten in der synthese von diltiazem. | |
| ATE19872T1 (de) | Verfahren zur herstellung von 2,4,6-triisocyanato-toluol. | |
| SE405732B (sv) | Sett att framstella derivat av dl-7-aminodesacetoxicefalosporansyra eller dl-7-tritylaminodesacetoxicefalosporansyra | |
| ATE104974T1 (de) | Verfahren zur herstellung eines pyrrol-derivats. | |
| DE59002152D1 (de) | Verfahren zur herstellung von 4-ketocarbonsaeuren und deren ester. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EELA | Cancelled due to lapse of time |